Muscarinic antagonist.html

 
ca de en es fr it nl no pl pt ru ro fi sv tr vo


 

A muscarinic receptor antagonist is an agent that reduces the activity of the muscarinic acetylcholine receptor. Most of them are synthetic, but scopolamine and atropine are belladonna alkaloids, and are naturally extracted.

Contents

Effects

Effect on central nervous system

Muscarinic antagonists stimulate the central nervous system (CNS) as a result of stimulation of medulla and higher cerebral centers. At low doses of atropine, it causes slight restlessness; at high or toxic doses it causes restlessness, agitation, and hallucinations. In atropine poisoning, marked excitation and agitation leads to hyperactivity and increase in body temperature through inhibition of sweating. Scopolamine in therapeutic doses causes CNS depression characterized by amnesia, fatigue and reduction in rapid eye movement sleep. Hyoscine has anti-emetic activity, so is used for motion sickness.

Antimuscarinics are also used as anti-parkinsonian drugs. In Parkinsonism, there is imbalance between levels of acetylcholine and dopamine in the brain, involving both increased levels of acetylcholine and degeneration of dopaminergic pathways (nigrostriatal pathway). Thus, in Parkinsonism there is decreased level of dopaminergic activity. One method of balancing the neurotransmitters is through blocking central cholinergic activity using muscarinic receptor antagonists.

Effect on heart

Atropine acts on the M2 receptors of the heart and antagonizes the activity of acetylcholine. It causes tachycardia by blocking vagal effects on the sinoatrial node. Acetylcholine hyperpolarizes the sinoatrial node which is overcome by MRA and thus increases the heart rate. If atropine is given by intramuscular or subcutaneous, it causes initial bradycardia. This is because by i.m/s.c it acts on presynaptic M1 receptors (autoreceptors). Intake of acetylcholine in axoplasm is prevented and the presynaptic nerve releases more acetylcholine into the synapse which initially causes bradycardia.

In the atrioventricular node, the resting potential is abbreviated which facilitates conduction. This is seen as a shortened PR-interval on an electrocardiogram.

It has an opposite effect on blood pressure. Tachycardia and stimulation of the vasomotor center causes an increase in blood pressure. But due to feed back regulation of the vasomotor center, there is fall in blood pressure due to vasodilation.

Important1 muscarinic antagonists include atropine, hyoscine, ipratropium, tropicamide, cyclopentolate and pirenzepine.

Comparison table

Substance Trade names Mechanism2 Clinical use2 Adverse effects2
Atropine (D/L-Hyoscyamine) non-selective antagonism, CNS stimulation
Scopolamine (L-Hyoscine) non-selective antagonism, CNS depression
Ipratropium non-selective antagonism, without any mucociliary excretion inhibition.
Tropicamide short acting non-selective antagonism, CNS depression
Pirenzepine M1 receptor-selective antagonist (fewer than non-selective ones)
Diphenhydramine Benadryl
Dimenhydrinate Dramamine
Dicyclomine
Flavoxate
Oxybutynin Ditropan
Tiotropium Spiriva
Cyclopentolate short acting non-selective antagonism, CNS depression
Atropine methonitrate non-selective antagonism, blocks transmission in ganglia
Trihexyphenidyl Artane
Tolterodine Detrusitol, Detrol
Solifenacin Vesicare
Darifenacin Enablex
Benzatropine Cogentin Reduces the effects of the relative central cholinergic excess that occurs as a result of dopamine deficiency. Anti-Parkinsonian drug
Mebeverine Colofac

See also

References

  1. ^ Rang, H. P. (2003). Pharmacology. Edinburgh: Churchill Livingstone. ISBN 0-443-07145-4.  Page 147
  2. ^ a b c Unless else specified in table boxes, then ref is: Rang, H. P. (2003). Pharmacology. Edinburgh: Churchill Livingstone. ISBN 0-443-07145-4.  Page 147

External links


All Right Reserved © 2007, Designed by Stylish Blog.